Understanding MACRA MIPS: Impact and Implications for Physicians

Understanding MACRA MIPS

Overview of MACRA MIPS

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) introduces the Merit-based Incentive Payment System (MIPS), a program designed to influence physician reimbursement under Medicare. This initiative not only governs physician finances but also establishes quality care standards across hospitals, practices, and clinics. Now in its fifth year since inception in 2017, MACRA MIPS plays a crucial role in streamlining the physician reimbursement process. While MIPS 2020 submission is manageable, it requires specific skills to achieve favorable scores.

Key Elements of MIPS

The MIPS program encompasses four primary categories aimed at promoting quality healthcare services:

1. **Quality**: This category replaces the Physician Quality Reporting System (PQRS) and emphasizes efforts to enhance care quality.
2. **Improvement Activities (IA)**: Focused on patient satisfaction, this category translates improvement activities into meaningful healthcare delivery.
3. **Promoting Interoperability (PI)**: This replaces the Advancing Care Information component, integrating technology into healthcare practices.
4. **Cost**: Replacing the value-based modifier program, this category assesses cost efficiency.

Each category carries different weights, which are subject to change annually under MACRA MIPS. Eligible clinicians who surpass the minimum performance threshold can earn positive payment adjustments and avoid penalties.

The Importance of MIPS for Healthcare Providers

MIPS and Large vs. Small Practices

Established medical practices are already familiar with the implications of MIPS data reporting. However, small healthcare organizations and non-eligible clinicians must gain a thorough understanding of MACRA MIPS. As the performance expectations rise, consulting a MIPS Qualified Registry for guidance is advisable, especially for smaller or underserved medical practices.

Benefits of MIPS Reporting

Physicians who submit data to CMS under MACRA MIPS can enjoy several advantages, including:

– Improved quality of care.
– Enhanced ranking among peers in the Physician Compare portal, leading to increased patient volume.
– Potential incentives for exceptional performance.
– Access to a portion of the $500 million bonus pool.

Although MACRA MIPS demands consistent effort, practices can seek assistance from MIPS consultants to navigate the process. For those with pending MIPS 2020 reporting, submissions are still accepted until March 31, 2021.

Reporting Data During the COVID-19 Pandemic

The Case for Reporting Despite Challenges

MIPS-eligible clinicians can benefit from reporting data even amid the COVID-19 pandemic. The potential incentives and bonus pool of $500 million present a worthwhile opportunity, along with improved reputations on the Physician’s Portal which can increase patient volume. The success of this effort hinges on how clinicians, groups, and virtual groups report data to CMS.

Clinicians should analyze their strengths and select MIPS Quality Measures that align with their practice. Reporting specialty-specific measures can maximize point accumulation, ultimately leading to a more efficient revenue cycle management.

Methods for Reporting MIPS Data

Eligible clinicians have various options for reporting MACRA MIPS data. The most straightforward and comprehensive method is through a MIPS Qualified Registry, such as P3Care. This registry focuses on submitting specialty-specific measures based on the final rule proposed by CMS.

Preparing for the MIPS 2021 Performance Year

Strategies for Effective Reporting

As we approach the midpoint of the QPP MIPS 2021 performance year, it is essential to strategize reporting efforts. Reporting requirements fluctuate annually, and MIPS consultants can assist in optimizing strategies to target incentives and bonuses. Clinicians are not required to report the Cost category, which CMS evaluates based on claims submissions. However, to maximize points in the Quality, Promoting Interoperability, and Improvement Activities categories, clinicians should be prepared to implement effective strategies.

This represents an opportunity to enhance revenue cycle management; any delays could adversely affect financial outcomes in 2023.

Conclusion

Submitting MIPS data under MACRA can be overwhelming, but it remains in the best interest of physicians to participate in the Quality Payment Program. With the financial challenges posed by COVID-19, incentive payment programs offer significant support. Furthermore, CMS has provided flexibility in administrative burdens. Therefore, participation in these programs is not only advisable but essential for the sustainability of medical practices.